Alpha Profiles · Company Profile

Tarsus Pharmaceuticals, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/tarsus-pharmaceuticals-inc

Entity: Public listing published
Primary listing: NASDAQ: TARS
Verification: Partially verified
Last reviewed: 2026-09-18T04:45:45.973951+00:00

Overview

Alpha's canonical identity and public leadership record for Tarsus Pharmaceuticals, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Aziz Mottiwala, MBA

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Bobak Azamian

President, Chief Executive Officer, and Board Chairman

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: TARS DEF 14A executive officersApr 28, 2026

Bobak Azamian, M.D., Ph.D.

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Bryan Wahl

General Counsel and Secretary

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: TARS DEF 14A executive officersApr 28, 2026

Bryan Wahl, M.D., J.D.

General Counsel and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Dianne Whitfield, MSW

Chief Human Resources Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Elizabeth Yeu-Lin, M.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Jeffrey Farrow

Chief Financial Officer and Chief Strategy Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Seshadri Neervannan, Ph.D.

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001819790-26-000028Apr 28, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 18, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.